Kalamazoo, Michigan — According to state and local economic development sources Pfizer plans to invest $120,000,000.00 to build out new space in Kalamazoo. The company plans to occupy the new space at 7000 Portage Rd in Kalamazoo, on or about December 1, 2023. According to the company website Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and womens health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

To learn more about Pfizer, visit http://www.pfizer.com/

Company Contact:
Albert Bourla, Chief Executive Officer
albert.bourla@pfizer.com
https://www.linkedin.com/in/albert-bourla/
212-733-2323

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved